Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain

BackgroundCancer therapy-related cardiac dysfunction due to trastuzumab has been well-known for many years, and echocardiographic surveillance is recommended every 3 months in patients undergoing trastuzumab treatment, irrespective of the baseline cardiotoxicity risk. However, the potential harm and...

Description complète

Détails bibliographiques

Auteurs principaux:	Giang M. Nhat, Nguyen H. Hai, Vo T. Duc, Ho H. Q. Tri, Chau N. Hoa
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2024-01-01
Collection:	Frontiers in Cardiovascular Medicine
Sujets:	early cancer therapy-related cardiotoxicity trastuzumab left ventricular global longitudinal strain left ventricular ejection fraction left atrial longitudinal strain right ventricular longitudinal strain
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1291180/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!